PharmaShots | Incisive News in 3 Shots

Subscribe Now

NMPA Approval

JW's Relmacabtagene Autoleucel Receives the NMPA's Approval for the Treatment of R/R Large B-Cell Lymphoma in China

JW's Relmacabtagene Autoleucel Receives the NMPA's Approval for the Treatment of R/R Large B-Cell Lymphoma in China

September 7, 2021

Mabpharm's Biobetter (CMAB008) for Infliximab Receives NMPA's Approval in China

Mabpharm's Biobetter (CMAB008) for Infliximab Receives NMPA's Approval in China

July 22, 2021

Teva's Austedo (deutetrabenazine) Receives the NMPA's Approval to Treat Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults

Teva's Austedo (deutetrabenazine) Receives the NMPA's Approval to Treat Chorea Associated with Huntington's Disease and Tardive Dy...

May 19, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us